NASDAQ:LGND - Ligand Pharmaceuticals SEC Filings & 10K Form

Sign in or create an account to add this stock to your watchlist.
$124.86 -4.31 (-3.34 %)
(As of 03/25/2019 06:00 AM ET)
Previous Close$124.86
Today's Range$124.85 - $129.57
52-Week Range$98.56 - $278.62
Volume556,496 shs
Average Volume758,394 shs
Market Capitalization$2.55 billion
P/E Ratio19.88
Dividend YieldN/A
Beta1.37

SEC Filings

Ligand Pharmaceuticals (NASDAQ:LGND) SEC Filings

DateFilerForm TypeView
03/15/2019
1:00 PM
FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/15/2019
12:59 PM
Aryeh Jason (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/15/2019
12:58 PM
HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/12/2019
9:02 AM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/06/2019
3:06 PM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/05/2019
4:16 PM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/13/2019
3:35 PM
Korenberg Matthew E (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/13/2019
3:35 PM
FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
02/13/2019
3:25 PM
Ligand Pharmaceuticals (Subject)
WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (Filed by)
Form SC 13G/A
View Filing
02/12/2019
3:27 PM
Ligand Pharmaceuticals (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Form SC 13G
View Filing
02/12/2019
10:31 AM
Ligand Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
View Filing
02/11/2019
10:06 AM
BlackRock Inc. (Filed by)
Ligand Pharmaceuticals (Subject)
Form SC 13G/A
View Filing
02/07/2019
5:19 PM
KOZARICH JOHN W (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 5
Annual statement of changes in beneficial ownership of securities  
View Filing
02/07/2019
3:16 PM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
02/06/2019
7:19 PM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/28/2019
8:00 AM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/25/2019
4:13 PM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
01/25/2019
3:32 PM
Berkman Charles S (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/25/2019
3:31 PM
FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/25/2019
3:31 PM
HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/25/2019
3:30 PM
Korenberg Matthew E (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/14/2019
8:17 AM
Berkman Charles S (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
01/14/2019
8:16 AM
HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/17/2018
7:01 PM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
12/17/2018
6:58 PM
Berkman Charles S (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/12/2018
4:32 PM
FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
12/06/2018
3:08 PM
Ligand Pharmaceuticals (Filer)
Form 8-K/A
View Filing
11/13/2018
4:03 PM
Ligand Pharmaceuticals (Filed by)
Viking Therapeutics, Inc. (Subject)
Form SC 13D/A
View Filing
11/13/2018
7:52 AM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
11/08/2018
7:13 AM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/25/2018
4:44 PM
Berkman Charles S (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/15/2018
11:55 AM
Davis Todd C (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/12/2018
5:52 PM
Berkman Charles S (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/10/2018
3:02 PM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
10/09/2018
3:24 PM
Davis Todd C (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/02/2018
5:24 PM
KOZARICH JOHN W (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
10/02/2018
5:24 PM
FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/27/2018
8:25 PM
Ligand Pharmaceuticals (Reporting)
Viking Therapeutics, Inc. (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/24/2018
5:05 AM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
09/18/2018
5:16 PM
Berkman Charles S (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/06/2018
9:40 AM
Ligand Pharmaceuticals (Issuer)
Sabba Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/05/2018
7:18 PM
FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/05/2018
7:00 PM
Berkman Charles S (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
09/05/2018
6:59 PM
LAMATTINA JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/31/2018
12:22 PM
HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/29/2018
7:35 PM
Korenberg Matthew E (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/24/2018
11:37 AM
Ligand Pharmaceuticals (Filer)
Form CT ORDER
View Filing
08/17/2018
6:38 PM
Aryeh Jason (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/17/2018
6:38 PM
Davis Todd C (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/17/2018
6:37 PM
HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/17/2018
6:37 PM
Ligand Pharmaceuticals (Issuer)
Patel Sunil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/09/2018
8:05 AM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
08/08/2018
4:17 PM
Ligand Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
08/07/2018
3:35 PM
Korenberg Matthew E (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
08/06/2018
3:02 PM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/30/2018
5:35 AM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/11/2018
3:00 PM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
07/03/2018
5:50 PM
KOZARICH JOHN W (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/03/2018
5:47 PM
Aryeh Jason (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4/A
View Filing
07/03/2018
5:45 PM
Davis Todd C (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4/A
View Filing
07/03/2018
5:43 PM
Gray Nancy Ryan (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4/A
View Filing
07/03/2018
5:42 PM
KOZARICH JOHN W (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4/A
View Filing
07/03/2018
5:39 PM
LAMATTINA JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4/A
View Filing
07/03/2018
5:37 PM
Ligand Pharmaceuticals (Issuer)
Patel Sunil (Reporting)
Form 4/A
View Filing
07/03/2018
4:05 PM
Ligand Pharmaceuticals (Issuer)
Sabba Stephen L (Reporting)
Form 4/A
View Filing
07/03/2018
2:27 PM
Korenberg Matthew E (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
07/03/2018
2:27 PM
Berkman Charles S (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/27/2018
3:08 PM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/21/2018
3:46 PM
Ligand Pharmaceuticals (Issuer)
Patel Sunil (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/21/2018
3:46 PM
Davis Todd C (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/21/2018
3:45 PM
Gray Nancy Ryan (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/21/2018
3:42 PM
Aryeh Jason (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/21/2018
3:42 PM
LAMATTINA JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/21/2018
3:41 PM
KOZARICH JOHN W (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/21/2018
11:32 AM
Ligand Pharmaceuticals (Issuer)
Sabba Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/19/2018
3:02 PM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
06/04/2018
6:01 PM
LAMATTINA JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
06/04/2018
5:10 AM
Ligand Pharmaceuticals (Filer)
Form DEFA14A
View Filing
05/22/2018
4:12 PM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/22/2018
2:48 PM
Ligand Pharmaceuticals (Filer)
Form CT ORDER
View Filing
05/18/2018
7:10 AM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/15/2018
5:41 PM
HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/11/2018
4:32 PM
FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
05/10/2018
5:07 AM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
05/09/2018
4:08 PM
Ligand Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
View Filing
05/08/2018
3:08 PM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/30/2018
3:22 PM
Ligand Pharmaceuticals (Filer)
Form DEFA14A
View Filing
04/30/2018
3:08 PM
Ligand Pharmaceuticals (Filer)
Form DEF 14A
View Filing
04/12/2018
7:50 PM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
04/03/2018
1:35 PM
Ligand Pharmaceuticals (Filer)
Form CT ORDER
View Filing
03/22/2018
3:06 PM
Ligand Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing
03/13/2018
5:15 PM
Ligand Pharmaceuticals (Issuer)
Sabba Stephen L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/09/2018
5:28 PM
Aryeh Jason (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/07/2018
5:03 AM
Ligand Pharmaceuticals (Filer)
Form 8-K/A
View Filing
03/06/2018
5:36 PM
LAMATTINA JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/06/2018
5:36 PM
Korenberg Matthew E (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/06/2018
5:36 PM
Berkman Charles S (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/06/2018
5:36 PM
HIGGINS JOHN L (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/06/2018
5:36 PM
FOEHR MATTHEW W (Reporting)
Ligand Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
View Filing
03/01/2018
3:48 PM
Ligand Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
View Filing
This page was last updated on 3/25/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel